Get access to Glenmark information and resources for stories in development.
Find recent and archived press releases.
Glenmark Pharmaceuticals secures its position in the prestigious Dow Jones Sustainability Emerging Markets Index for the second year in a row
September 26, 2019
Glenmark Receives Orphan Drug Designation for GBR 1342, a Bispecific Antibody Candidate Under Evaluation for the Treatment of Multiple Myeloma
September 16, 2019
Glenmark Pharmaceuticals receives ANDA approval for Clobetasol Propionate Foam, 0.05% (Emulsion Formulation)
September 10, 2019
August 26, 2019